HansaBioMed Life Sciences OU of Tallinn at MEDICA 2020 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

HansaBioMed Life Sciences OU

Mäealuse 2/1, 12618 Tallinn
Estonia

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Enterprise Estonia EAS

Contact

Ph.D. Paolo Guazzi

COO

Ph.D. Kadi-Liis Veiman

Head of Production

Ph.D. Mart Toots

Innovation and R&D

Phone
+37256499651

Email
mart@hansabiomed.eu

Our products

Product category: Molecular biomarkers

EV purification and characterization service

Custom isolation of EVs from biofluids, CCM and plant extracts:
  • Scalable purification using TFF and/or SEC
  • Small and large EV isolation
  • Validation: NTA, protein content, TEM, EV marker expression
Phenotyping:
  • fNTA
  • High-throughput protein marker analyses - biomarker discovery
  • Flow cytometry using NanoFCM
OMICS analyses
  • Mass-spectrometry
  • RNA and DNA next-generation sequencing
  • Metabolomics analyses

More Less

Product category: Molecular biomarkers

Purified Extracellular Vesicles (EVs)

Lyophilized Exosomes and Microvesicles are obtained from a variety of biological sources: cell culture supernatant, human plasma, serum, urine and saliva of pool of healthy donors. Exosomes (40-120 nm) are purified following a combination of tangential flow filtration (TFF) and size exclusion chromatography (SEC). Microvesicles (150- 1000 nm) are separated using TFF-MV.
HBM can also provide fluorescent labeled Exosome Standards from human biofluids or cell media for EV tracking in fluorescence microscopy experiments.

Applications: Assay calibration, Control (spike-in) for EV quantification, protein marker analysis using different techniques. Extraction and analysis of EV associated nucleic acids. Flow cytometry. Electron microscopy.

More Less

Product category: Molecular biomarkers

Tangential flow filtration (TFF) devices

Tangential flow filtration (TFF) is a rapid and efficient method, usually used for separation and purification of biomolecules. TFF can be also used to concentrate and desalt sample solutions, and is emerging as a new technique for EV isolation.
We offer filters with various cut-offs for isolation of EVs of specific size 

More Less

Product category: Molecular biomarkers

Size Exclusion Chromatography (SEC) columns

Size Exclusion Chromatography (SEC) is considered one of the best methods for isolating and purifying Extracellular Vesicles (EVs) from different matrices, since it allows for fast and efficient separation of EVs from circulating proteins and preservs the original shape and functionality of the vesicles.

More Less

Product category: Molecular biomarkers

EV-Spinner

EV-Spinner is a 2.5 ml non-stick ultrafiltration (UF) concentrator to enhance the recovery of extracellular vesicle (EVs) during the concentration or buffer exchange step. The ultrafiltration works in the opposite direction to the centrifugal force, providing higher particle recovery. The low protein binding membrane (polyethersulphone) reduces the EV loss, compared to V-shape concetrators, and the reverse design of the EV-spinner ensures that the filter does not clog.

More Less

Product category: Molecular biomarkers

SelectEV, Liquid Biopsy DNA isolation kit

SeleCTEV™ DNA Enrichment Kit allows the selective purification of circulating free DNA (cfDNA) and tumor-derived extracellular vesicles (EVs) DNA  from plasma. The isolation is based on Exosomics’  proprietary peptide affinity method. Enables  better downstream analytical performance.

More Less

Product category: Molecular biomarkers

SortEV: liquid biopsy RNA enrichment kit

SoRTEV™ RNA Enrichment Kit allows the selective purification of tumor-derived extracellular vesicles (EVs) RNA from plasma. The isolation is based on immuno-affinity binding to beads coated with Exosomics’ proprietary antibodies against exosome surface antigens. Enables the next generation of RNA-based tumor diagnostics assays.

More Less

Product category: Molecular biomarkers

ExoREF: tumor-derived reference standard for liquid biospy

ExoRef™ are ev-based reference standards containing cancer-relevant mutations and can be used for evaluating your extracellular vescicles (EVs) isolation, assessing the extraction of DNA from EVs, monitoring your ev-based DX workflow

More Less

Product category: Molecular biomarkers

EV-free plasma

Every diagnostic test as well as R&D need references and controls. EV-free Plasma is a human recreated plasma which contains all the components of the original fluid,  with exception of extracellular vesicles and exosomes.

More Less

Product category: Molecular biomarkers

EV-GAG: high EV recovery for biomarker discovery

evGAG is a patented purification method that allows isolation of extracellular vesicles (EVs) from biofluids. The evGAG precipitation reaction is based on the interaction between the precipation solution and glycosaminoglycans (GAGs) in the EVs.

More Less

About us

Company details

HansaBioMed Life Sciences Ltd is  to research and development of products in the field of Extracellular Vesicles (EVs).

Its mission is to develop and commercialize proprietary platforms, kits, reagents and equipment for EV research in the Life Sciences market.

Our facilities are located in Tallinn (Estonia), in the Tallinn Technology Park (Tehnopol). HansaBioMed Life Sciences offers the widest choice and selection of products dedicated to EV research for Life Science applications available on the global market today. Our scientists have over 10 years of experience in the area of Extracellular Vesicles, high background in molecular and cell biology, in cancer research, and development of diagnostics.

HBM has an active research program; it is a partner in several H2020 projects, and is leading 2 product development and basic science grants.

Starting from 2019 HansaBioMed Life Sciences belongs to Exosomics S.p.A.

More Less

Company data

Sales volume

< 1 Mio US $

Export content

> 75%

Number of employees

1-19

Area of business

Diagnostics

Company information as a PDF file